E. Roeseler

1.1k total citations
14 papers, 603 citations indexed

About

E. Roeseler is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, E. Roeseler has authored 14 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Economics and Econometrics. Recurrent topics in E. Roeseler's work include Lipoproteins and Cardiovascular Health (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Pharmaceutical Economics and Policy (5 papers). E. Roeseler is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Pharmaceutical Economics and Policy (5 papers). E. Roeseler collaborates with scholars based in Germany, Austria and Colombia. E. Roeseler's co-authors include Franz Heigl, Ulrich Julius, Anja Vogt, Reinhard Klingel, Wolfgang Ramlow, Andreas Heibges, Dennis Heutling, Josef Leebmann, Winfried Maerz and Walter Lehmacher and has published in prestigious journals such as Circulation, Atherosclerosis and Nature Reviews Cardiology.

In The Last Decade

E. Roeseler

14 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Roeseler Germany 9 540 235 168 117 91 14 603
O. Afanasieva Russia 15 459 0.8× 230 1.0× 96 0.6× 54 0.5× 141 1.5× 82 622
C. Stefanutti Italy 10 339 0.6× 118 0.5× 153 0.9× 24 0.2× 79 0.9× 20 498
D. Datta United Kingdom 7 293 0.5× 127 0.5× 118 0.7× 67 0.6× 33 0.4× 22 375
A. Vivenzio Italy 14 275 0.5× 144 0.6× 147 0.9× 22 0.2× 68 0.7× 27 425
Kazuhiko Makino Japan 9 373 0.7× 151 0.6× 155 0.9× 14 0.1× 57 0.6× 11 511
Claudia Morozzi Italy 12 235 0.4× 117 0.5× 77 0.5× 20 0.2× 40 0.4× 19 332
Robert A. Hegele Canada 5 509 0.9× 158 0.7× 241 1.4× 55 0.5× 31 0.3× 5 641
Craig Balog United States 10 478 0.9× 486 2.1× 97 0.6× 21 0.2× 54 0.6× 11 736
S. J. Leslie United States 4 337 0.6× 189 0.8× 65 0.4× 42 0.4× 86 0.9× 4 448
Stephen Jones Australia 6 265 0.5× 84 0.4× 27 0.2× 67 0.6× 57 0.6× 11 386

Countries citing papers authored by E. Roeseler

Since Specialization
Citations

This map shows the geographic impact of E. Roeseler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Roeseler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Roeseler more than expected).

Fields of papers citing papers by E. Roeseler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Roeseler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Roeseler. The network helps show where E. Roeseler may publish in the future.

Co-authorship network of co-authors of E. Roeseler

This figure shows the co-authorship network connecting the top 25 collaborators of E. Roeseler. A scholar is included among the top collaborators of E. Roeseler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Roeseler. E. Roeseler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Schettler, Volker, Christian Peter, Thomas Zimmermann, et al.. (2022). The German Lipoprotein Apheresis Registry—Summary of the ninth annual report. Therapeutic Apheresis and Dialysis. 26(S1). 81–88. 13 indexed citations
2.
Schettler, Volker, Christian Peter, Thomas Zimmermann, et al.. (2021). The German Lipoprotein Apheresis Registry (GLAR) – more than 7 years on. Atherosclerosis. 331. e21–e21. 3 indexed citations
3.
Schettler, Volker, C. Neumann, Christian Peter, et al.. (2019). Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels. PubMed. 14(S1). 33–38. 24 indexed citations
4.
Klingel, Reinhard, Franz Heigl, Volker Schettler, et al.. (2019). Lipoprotein(a) – Marker for cardiovascular risk and target for lipoprotein apheresis. Atherosclerosis Supplements. 40. 17–22. 8 indexed citations
5.
Heigl, Franz, Tobias Pflederer, Reinhard Klingel, et al.. (2019). Lipoprotein apheresis in Germany – Still more commonly indicated than implemented. How can patients in need access therapy?. Atherosclerosis Supplements. 40. 23–29. 7 indexed citations
6.
Schettler, Volker, C. Neumann, Christian Peter, et al.. (2017). Current insights into the German Lipoprotein Apheresis Registry (GLAR) – Almost 5 years on. Atherosclerosis Supplements. 30. 50–55. 19 indexed citations
7.
Schettler, Volker, et al.. (2017). Extrem niedrige LDL-Cholesterinkonzentrationen durch moderne lipidsenkende Therapien. CardioVasc. 17(4). 54–57. 1 indexed citations
8.
Schettler, Volker, C. Neumann, Christian Peter, et al.. (2017). The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on. PubMed. 12(S1). 44–49. 30 indexed citations
9.
Schettler, Volker, J Ringel, Ulrich Julius, et al.. (2017). Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?. Atherosclerosis Supplements. 30. 44–49. 4 indexed citations
10.
Schettler, Volker, et al.. (2015). Differenzierung der Indikation zur Lipoproteinapherese bei erhöhtem Lp(a) durch unterschiedliche Messmethoden. CardioVasc. 15(3). 36–38. 4 indexed citations
11.
Schettler, Volker, C. Neumann, Christian Peter, et al.. (2015). Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels. PubMed. 10(S1). 14–20. 11 indexed citations
12.
Schettler, Volker, C. Neumann, Christian Peter, et al.. (2015). First data from the German Lipoprotein Apheresis Registry (GLAR). Atherosclerosis Supplements. 18. 41–44. 22 indexed citations
13.
Leebmann, Josef, E. Roeseler, Ulrich Julius, et al.. (2013). Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease. Circulation. 128(24). 2567–2576. 232 indexed citations
14.
Jaeger, B.R., Dorothea Nagel, Franz Heigl, et al.. (2009). Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events. Nature Reviews Cardiology. 6(3). 229–239. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O. Afanasieva Breakdown of academic impact, for papers by C. Stefanutti Breakdown of academic impact, for papers by D. Datta Breakdown of academic impact, for papers by A. Vivenzio Breakdown of academic impact, for papers by Kazuhiko Makino Breakdown of academic impact, for papers by Claudia Morozzi Breakdown of academic impact, for papers by Robert A. Hegele Breakdown of academic impact, for papers by Craig Balog Breakdown of academic impact, for papers by S. J. Leslie Breakdown of academic impact, for papers by Stephen Jones
Rankless by CCL
2026